Plaintiffs Amarin Pharma Inc. and Amarin Pharmaceuticals Ireland Limited (collectively, “Amarin” or “Plaintiffs”), by and through its attorneys of record, hereby move for partial summary judgment rejecting all of Defendants’ affirmative defenses and counterclaims asserting invalidity, to the extent that said affirmative defenses and counterclaims allege that any asserted claim is anticipated under 35 U.S.C. § 102, or invalid under 35 U.S.C. § 112.1 This Motion is made and based upon the pleadings and papers on file herein, the below Memorandum of Points and Authorities, the Declaration of Michael N. Kennedy filed contemporaneously with this Motion, as well as any argument of counsel the Court may allow at any hearing on this Motion.